dc.creatorAcurio Paez, Fausto David
dc.date.accessioned2023-06-30T17:41:48Z
dc.date.accessioned2023-08-10T15:16:07Z
dc.date.available2023-06-30T17:41:48Z
dc.date.available2023-08-10T15:16:07Z
dc.date.created2023-06-30T17:41:48Z
dc.date.issued2016
dc.identifier2661-6777
dc.identifierhttp://dspace.ucuenca.edu.ec/handle/123456789/42324
dc.identifierhttps://pesquisa.bvsalud.org/portal/resource/es/biblio-999540
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8152222
dc.description.abstractThe document includes the discussion of the access to medicines, it shows how there are millions of people who need essential medicines and have no access to them, and by the other hand, the industry maintains a continuous increase in its profits, and it shows how a contradiction is presented because the industries have prioritized research, development and production of the most profitable products, and not always the most needed products. It is argued that a public policy that seeks to promote access to medicines should be based on establishing lists of essential drugs and promotes rational use of them, also they should establish mechanisms of pricing and regulations that allow facing the imperfect nature drug market.
dc.languagees_ES
dc.sourceRevista de la Facultad de Ciencias Médicas de la Universidad de Cuenca
dc.subjectIndustria Farmacéutica
dc.subjectSalud pública
dc.subjectSistemas de salud
dc.subjectPrecio de medicamento
dc.subjectAcceso a Medicamentos esenciales y tecnologías sanitarias
dc.titlePolíticas públicas y acceso a medicamentos en el Ecuador
dc.typeARTÍCULO


Este ítem pertenece a la siguiente institución